You are here

Sanofi

Despite scoring an FDA nod, Merck's biosim Lusduna must wait to challenge Lantus

Despite scoring an FDA nod, Merck's biosim Lusduna must wait to challenge Lantus

Fierce Pharma

Hatch Waxman Act

Flag link:

Sanofi offers Ablynx billions of biobucks for nanobody partnership

Sanofi offers Ablynx billions of biobucks for nanobody partnership

Fierce Biotech

Flag link:

With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round

With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round

Endpoints

Flag link:

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

Fierce Pharma

Flag link:

Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent

Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent

Fierce Pharma

Flag link:

Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy

Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy

Fierce Pharma

Protein Sciences

Flag link:

Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses

Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses

Bloomberg

Flag link:

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Bloomberg

healthcare reform

Jazz Pharmaceuticals

Vertex Pharmaceuticals

Flag link:

Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug

Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug

Endpoints

clinical trials

Flag link:

EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts

EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts

Fierce Biotech

artificial intelligence

Silence Therapeutics

Flag link:

Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication

Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication

Fierce Pharma

Department of Defense

Flag link:

Senators lay into Sanofi for Zika vaccine deal, call for public hearing

Senators lay into Sanofi for Zika vaccine deal, call for public hearing

Fierce Pharma

Flag link:

Regeneron’s Praluent May See Gradual Increase in 2017 Demand

Regeneron’s Praluent May See Gradual Increase in 2017 Demand

Market Realist

Flag link:

Sanofi: A Good Bet On Pharma

Sanofi: A Good Bet On Pharma

Seeking Alpha

Flag link:

Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"

Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"

Reuters

Olivier Brandicourt

Flag link:

Sanofi, Parexel collaborate on clinical trial data collection wearables

Sanofi, Parexel collaborate on clinical trial data collection wearables

Drug Delivery Business News

clinical trials

clinical trial data

Flag link:

Lexicon Pharma Goes Three For Three With Sotagliflozin Data

Lexicon Pharma Goes Three For Three With Sotagliflozin Data

Seeking Alpha

Lexicon Pharmaceuticals

type 1 diabetes

Flag link:

Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro

Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro

Fierce Pharma

Gilead Sciences

Flag link:

Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics

Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics

Fierce Pharma

LDL cholesterol

Flag link: